Roche and UCLA have reached an agreement that will provide the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and UCLA’s Jonsson Comprehensive Cancer Center with access to the latest in genomic technologies from Roche’s research and development pipeline.
